Evaluation of the use of anti-TNF-α in an LPS-induced murine model

Journal of Reproductive Immunology

Volumn 78, Issue 2, 2008, Pages 134-139

  Holmgren, C ^a,b   Esplin, M S ^a,b   Hamblin, S ^a   Molenda, M ^c   Simonsen, S ^a   Silver, R ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b INTERMOUNTAIN HEALTHCARE   (United States)

^c CENTOCOR INC   (United States)

Author keywords

Anti TNF ; Fetal death; Preterm delivery

Indexed keywords

CD14 ANTIGEN; CYCLOOXYGENASE 1; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; SODIUM CHLORIDE; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EVALUATION; FEMALE; FETUS DEATH; GENE EXPRESSION; MOUSE; NONHUMAN; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUP (RODENT); REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK REDUCTION; STATISTICAL SIGNIFICANCE;

ANIMALS; ANTIBODIES; CYTOKINES; FEMALE; FETAL DEATH; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREMATURE BIRTH; TUMOR NECROSIS FACTOR-ALPHA;

EID: 46549087064     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2007.11.003     Document Type: Article

References (34)

1. Ananth C.V., Joseph K.S., Oyelese Y., Demissie K., and Vintzileos A.M. Trends in preterm birth and perinatal mortality among singletons: United States, 1989 through 2000. Obstet. Gynecol. 105 (2005) 1084-1091
2. Arias E., MacDorman M.F., Strobino D.M., and Guyer B. Annual summary of vital statistics. Pediatrics 112 (2003) 1215
3. Arnott I., McDonald D., Williams A., and Ghosh S. Clinical use of Infliximab in Crohn's disease: the Edinburgh experience. Aliment. Pharmacol. Ther. 15 (2001) 1639-1646
4. Blumenauer B., Judd M., Cranney A., et al. Etanercept for the treatment of rheumatoid arthritis. Cochrane Database Syst. Rev. (2003) CD004525
5. Chakravarty E.F., Sanchez-Yamamoto D., and Bush T.M. The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes. J. Rheumatol. 30 (2003) 241-246
6. Crider K., Whitehead N., and Buus R. Genetic variation associated with preterm birth: a HuGE review. Genet. Med. 7 (2005) 593-604
7. Elovitz M.A., and Mrinalini C. Can medroxyprogesterone acetate alter Toll-like receptor expression in a mouse model of intrauterine inflammation?. Am. J. Obstet. Gynecol. 193 (2005) 1149-1155
8. Fidel Jr. P., Romero R., Cutright J., et al. Treatment with the interleukin-I receptor antagonist and soluble tumor necrosis factor receptor Fc fusion protein does not prevent endotoxin-induced preterm parturition in mice. J. Soc. Gynecol. Investig. 4 (1997) 22-26
9. Fidel Jr. P.L., Romero R., Wolf N., et al. Systemic and local cytokine profiles in endotoxin-induced preterm parturition in mice. Am. J. Obstet. Gynecol. 170 (1994) 1467-1475
10. Fortunato S.J., Menon R.P., Swan K., and Menon R. Inflammatory cytokine (interleukins 1, 6 and 8 and tumor necrosis factor-alpha) release from cultured human fetal membranes in response to endotoxic lipopolysaccharide mirrors amniotic fluid concentrations. Am. J. Obstet. Gynecol. 174 (1996) 1855-1861
11. Fujihara M., Muroi M., Tanamoto K., Suzuki T., Azuma H., and Ikeda H. Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol. Ther. 100 (2003) 171-194
12. Gendron R., Nestel F., Lapp W., and Baines M. Lipopolysaccharide-induced fetal resorption in mice is associated with the intrauterine production of tumour necrosis factor-alpha. J. Reprod. Fertil. 90 (1990) 395-402
13. Gravett M.G., Novy M.J., et al. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA 292 (2004) 462-469
14. Hamilton B.E., Martin J.A., and Sutton P.D. Births: preliminary data for 2002. In National Vital Statistics Reports from the Centers for Disease Control and Prevention vol. 51 (2003), National Center for Health Statistics, National Vital Statistics System pp. 1-20
15. Hillier S.L., Martius J., Krohn M., Kiviat N., Holmes K.K., and Eschenbach D.A. A case-control study of chorioamnionitis in prematurity. N. Engl. J. Med. 319 (1988) 972-978
16. Hirsch E., Filipovich Y., and Mahendroo M. Signaling via the type I IL-1 and TNF receptors is necessary for bacterially induced preterm labor in a murine model. Am. J. Obstet. Gynecol. 194 (2006) 1334-1340
17. Hirsch E., Muhle R., Mussalli G., and Blanchard R. Bacterially induced preterm labor in the mouse does not require maternal interleukin-1 signaling. Am. J. Obstet. Gynecol. 186 (2002) 523-530
18. Hirsch E., and Wang H. The molecular pathophysiology of bacterially induced preterm labor: insights from the murine model. J. Soc. Gynecol. Investig. 12 (2005) 145-155
19. Katz J.A., Antoni C., Keenan G.F., Smith D.E., Jacobs S.J., and Lichtenstein G.R. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am. J. Gastroenterol. 99 (2004) 2385-2392
20. Kim Y.M., Romero R., Chaiworapongsa T., et al. Toll-like receptor-2 and -4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis. Am. J. Obstet. Gynecol. 191 (2004) 1346-1355
21. Lin Y., Xie M., Chen Y., Di J., and Zeng Y. Preterm delivery induced by LPS in syngeneically impregnated BALB/c and NOD/SCID mice. J. Reprod. Immunol. 71 (2006) 87-101
22. Moore K.W., de Waal Malefyt R., Coffman R.L., and O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19 (2001) 683-765
23. Muzio M., Polentarutti N., Bosisio D., Manoj Kumar P.P., and Mantovani A. Toll-like receptor family and signalling pathway. Biochem. Soc. Trans. 28 (2000) 563-566
24. Pestka S., Krause C.D., Sarkar D., Walter M.R., Shi Y., and Fisher P.B. Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. 22 (2004) 929-979
25. Rath W., Winkler M., and Kemp B. The importance of extracellular matrix in the induction of preterm delivery. J. Perinat. Med. 26 (1998) 437-441
26. Robertson S.A., Skinner R.J., and Care A.S. Essential role for IL-10 in resistance to lipopolysaccharide-induced preterm labor in mice. J. Immunol. 177 (2006) 4888-4896
27. Romero R., and Mazor M. Infection and preterm labor. Clin. Obstet. Gynecol. 31 (1988) 553-584
28. Romero R., Mazor M., Sepulveda W., Avila C., Copeland D., and Williams J. Tumor necrosis factor in preterm and term labor. Am. J. Obstet. Gynecol. 166 (1992) 1576-1587
29. Romero R., Sirtori M., Oyarzun E., Avila C., Mazor M., and Callahan R. Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am. J. Obstet. Gynecol. 161 (1989) 817-824
30. Sadowsky D.W., Adams K.M., Gravett M.G., Witkin S.S., and Novy M.J. Preterm labor is induced by intraamniotic infusions of interleukin-1beta and tumor necrosis factor-alpha but not by interleukin-6 or interleukin-8 in a nonhuman primate model. Am. J. Obstet. Gynecol. 195 (2006) 1578-1589
31. Silver R.M., Edwin S.S., Umar F., Dudley D.J., Branch D.W., and Mitchell M.D. Bacterial lipopolysaccharide-mediated murine fetal death: the role of interleukin-1. Am. J. Obstet. Gynecol. 176 (1997) 544-549
32. Silver R., Lohner W., Daynes R., Mitchell M., and Branch D. Lipopolysaccharide-induced fetal death: the role of tumor-necrosis factor-alpha. Biol. Reprod. 50 (1994) 1108-1112
33. Tanaka Y., Narahara H., Takai N., Yoshimatsu J., Anai T., and Miyakawa I. Interleukin-1ß and interleukin-8 in cervicovaginal fluid during pregnancy. Am. J. Obstet. Gynecol. 79 (1998) 644-649
34. Xu D., Chen Y., Wang H., Zhao L., Wang J., and Wei W. Tumor necrosis factor alpha partially contributes to lipopolysaccharide-induced intra-uterine fetal growth restriction and skeletal development retardation in mice. Toxicol. Lett. 163 (2006) 20-29